EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patterns, Potential Teratogenicity, and Associated Factors of Drugs Prescribed to Pregnant Women Attending Antenatal Care Units in Debre Tabor Comprehensive Specialized Hospital, Debre Tabor, Northwest Ethiopia

Muluken Adela Alemu iD, Woretaw Sisay Zewdu iD, Yared Andargie Ferede iD, Mulugeta Molla Zeleke iD, Teklie Mengie Ayele iD, Abraham Nigussie Assefa iD, Tirsit Ketsela Zeleke iD, Achenef Bogale Kassie iD

BioMed Research International · 2024

DOI: 10.1155/2024/5577862 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioMed Research International, 2024. Verfasst von Muluken Adela Alemu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, College of Health Sciences, Debre Tabor University, PO Box 272, Debre Tabor, Ethiopia. Hauptthemen laut MEDLINE: Prenatal Care. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

About 80% of pregnant women use at least one medication during their pregnancy period. Many drugs that are not allowed to be used during pregnancy (from FDA Pregnancy Categories D and X) were used. Irrational use of these drugs during pregnancy may result in different birth defects, as explained by thalidomide and diethylstilbestrol’s tragedy. Knowledge of drug utilization and associated factors that affect the pattern is important to enhance rational prescribing. But information about prescription patterns and associated factors among pregnant women is scarce in the Debre Tabor area and generally in Ethiopia.

Objective

This study was aimed at assessing drug prescription patterns, potential teratogenicity, and associated factors among pregnant women attending the antenatal care unit at Debre Tabor Comprehensive Specialized Hospital, Debre Tabor, Northwest Ethiopia.

Methods

A retrospective cross‐sectional study design was performed on 359 pregnant women attending antenatal care units from June 01, 2022, to August 30, 2022, in the hospital. Necessary data were obtained through a questionnaire by reviewing the medical charts of the women. Analysis of the data was performed using SPSS Version 23. The association of the independent variables to medication use was assessed using multivariate logistic regression. A p value of less than 0.05 was considered significant.

Results

Most of the study participants (325/359) were married (90.5%). From a total of 359 participants, 350 (97.5%) were prescribed with drugs. About 64% (385/602) of the prescribed medications were iron and vitamins. The most commonly prescribed medications are iron and folic acid combination (340/602, 56.5%), albendazole (48/602, 8%), mebendazole (37/602, 6.1%), omeprazole (33/602, 5.5%), followed by amoxicillin (32/602, 5.3%). The majority (79.3%) of the drugs were from FDA Pregnancy Categories A and B. Prescribed drug utilization was more probable in women who first visited the facility at their second (AOR = 2.91, 95% CI [1.12–6.64]) and third trimesters (AOR = 4.32, 95% CI [1.37–6.81]), had chronic illness (AOR = 7.54, 95% CI [2.34–14.68]), and live in rural areas (AOR = 2.47, 95% CI [1.56–8.43]).

Conclusion

The study revealed that the prescription pattern in the hospital is in line with the WHO reference. Age, gravidity, number of ANC visits, first visit to the facility, presence of chronic illness, educational status, and residency were significantly associated with prescription drug use in pregnant mothers. But still, some pregnant women received drugs that may have teratogenicity risk (FDA Category C).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prenatal CareHumansFemaleEthiopiaPregnancyAdultCross-Sectional StudiesPregnant PeopleYoung AdultAdolescentRetrospective StudiesDrug PrescriptionsTeratogens

Stichwörter der Autor:innen

Debre Tabor Comprehensive Specialized Hospitalpregnancyteratogenicity

Substanzen

Teratogens

Autor:innen und Institutionen

  • Department of Pharmacy, College of Health Sciences, Debre Tabor University, PO Box 272, Debre Tabor, Ethiopia.
  • Department of Pharmacy, College of Health Sciences, Debre Markos University, PO Box 269, Debre Markos, Ethiopia.

ORCID-Profile: Muluken Adela Alemu, Woretaw Sisay Zewdu, Yared Andargie Ferede, Mulugeta Molla Zeleke, Teklie Mengie Ayele, Abraham Nigussie Assefa, Tirsit Ketsela Zeleke, Achenef Bogale Kassie

Zitieren

APA

Alemu, M. A., Zewdu, W. S., Ferede, Y. A., Zeleke, M. M., Ayele, T. M., Assefa, A. N., Zeleke, T. K., & Kassie, A. B. (2024). Patterns, Potential Teratogenicity, and Associated Factors of Drugs Prescribed to Pregnant Women Attending Antenatal Care Units in Debre Tabor Comprehensive Specialized Hospital, Debre Tabor, Northwest Ethiopia. BioMed Research International. https://doi.org/10.1155/2024/5577862

Vancouver

Alemu MA, Zewdu WS, Ferede YA, Zeleke MM, Ayele TM, Assefa AN, et al. Patterns, Potential Teratogenicity, and Associated Factors of Drugs Prescribed to Pregnant Women Attending Antenatal Care Units in Debre Tabor Comprehensive Specialized Hospital, Debre Tabor, Northwest Ethiopia. BioMed Research International. 2024. doi:10.1155/2024/5577862

BibTeX
@article{Alemu2024,
  author = {Alemu, Muluken Adela and Zewdu, Woretaw Sisay and Ferede, Yared Andargie and Zeleke, Mulugeta Molla and Ayele, Teklie Mengie and Assefa, Abraham Nigussie and Zeleke, Tirsit Ketsela and Kassie, Achenef Bogale},
  title = {Patterns, Potential Teratogenicity, and Associated Factors of Drugs Prescribed to Pregnant Women Attending Antenatal Care Units in Debre Tabor Comprehensive Specialized Hospital, Debre Tabor, Northwest Ethiopia},
  journal = {BioMed Research International},
  year = {2024},
  doi = {10.1155/2024/5577862}
}
Kostenlos starten →